One-hundred sixteen patients were given nalbuphine by 10 specifically
trained ambulance paramedics over a 9-month period. Forty-seven had su
spected myocardial infarction and 69 had sustained trauma or burns. Th
e mean pain score measured by a 10-cm visual analogue scale fell from
8 before analgesia to 3. This was highly significant. There were no se
rious side effects. We conclude that nalbuphine can be safely administ
ered by trained paramedics to provide effective analgesia to those in
pain in a prehospital setting.